Xtl Biopharmaceuticals XTLB
NASDAQ XTLB
$2.15 -0.10 (-4.44%)
At close: Oct 2, 2026 · 4:00 PM EDT

Xtl Biopharmaceuticals (XTLB) Cash & Current Investments (2009 - 2025)

Updated

Xtl Biopharmaceuticals (XTLB) recorded Cash & Current Investments of $76,000 in the quarter ended Dec 31, 2025, down 93.4% from $1.14 million a year earlier.

Analysis

Xtl Biopharmaceuticals (XTLB) Cash & Current Investments (2009 - 2025) Analysis & Trends

Starting with the quarter ended Mar 31, 2009, Xtl Biopharmaceuticals' Cash & Current Investments history includes 65 quarters.

  • Annual Cash & Current Investments has declined for five straight years, with a five-year compound annual growth rate of -59.4% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Cash & Current Investments came in at $1.14 million in the year ended Dec 31, 2024 (-57.7%), $2.7 million in the year ended Dec 31, 2023 (-41.3%), $4.6 million in the year ended Dec 31, 2022 (-32.3%) and $6.79 million in the year ended Dec 31, 2021 (-1.1%).
  • The figure for the quarter ended Dec 31, 2025 is the lowest quarterly Cash & Current Investments in data going back to the quarter ended Mar 31, 2009.
  • Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 56.4% in the quarter ended Jun 30, 2021, against a decline of 93.4% in the quarter ended Dec 31, 2025 at the low end.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Xtl Biopharmaceuticals 2.03 Bn 2.03 Bn - 76,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 76,000.00
Jun 30, 2025 259,000.00
Dec 31, 2024 1.14 Mn
Sep 30, 2024 1.72 Mn
Jun 30, 2024 1.59 Mn
Mar 31, 2024 2.34 Mn
Dec 31, 2023 2.01 Mn
Sep 30, 2023 2.21 Mn
Jun 30, 2023 2.38 Mn
Mar 31, 2023 2.88 Mn
Dec 31, 2022 3.72 Mn
Sep 30, 2022 4.39 Mn
Jun 30, 2022 5.16 Mn
Mar 31, 2022 2.79 Mn
Dec 31, 2021 6.13 Mn
Sep 30, 2021 3.01 Mn
Jun 30, 2021 6.30 Mn
Mar 31, 2021 3.39 Mn
Dec 31, 2020 6.04 Mn
Sep 30, 2020 3.75 Mn
API Access

Xtl Biopharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=XTLB&period=max&api_key=YOUR_API_KEY